Last Price
0.004
Today's Change
+0.001 (33.33%)
Day's Change
0.004 - 0.004
Trading Volume
16,862,568
Overview
Market Cap
8 Million
Shares Outstanding
2 Billion
Avg Volume
1,497,968
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.01
PE Ratio
0.00
EPS
0.00
Earnings Announcement
21-Feb-2025
Previous Close
0.00
Open
0.00
Day's Range
0.004 - 0.004
Year Range
0.003 - 0.011
Trading Volume
16,862,568
Price Change Highlight
1 Day Change
33.33%
5 Day Change
0.00%
1 Month Change
33.33%
3 Month Change
-33.33%
6 Month Change
-55.56%
Ytd Change
-50.00%
1 Year Change
-50.00%
3 Year Change
-89.47%
5 Year Change
-78.95%
10 Year Change
-75.62%
Max Change
-99.30%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates cell nuclei. The company also focuses on developing PAT-DX1, an antibody fragment for the treatment of primary and secondary brain cancer. In addition, it is developing PAT-DX3, a full-sized antibody that has DNA-binding and DNA damage repair blocking properties of PAT-DX1 used for tissue distribution, pharmacokinetic profile, etc.; and PAT-DX1-NP, a product based on the targeted delivery of nanoparticles carrying therapeutic payloads to the inside of cancer cells. The company was incorporated in 2006 and is based in Melbourne, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
RBA Holds Key Rate at 13-year High as World Waits on US Vote
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
